Patrick J Heron's Insider Trades & SAST Disclosures
Patrick J Heron's most recent trade in Arcutis Biotherapeutics Inc was a trade of 2,520 Common Stock done at an average price of $13.7 . Disclosure was reported to the exchange on May 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Patrick J Heron.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 13.66 per share. | 21 May 2025 | 2,520 | 20,014 (0%) | 0% | 13.7 | 34,423 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 13.65 per share. | 21 May 2025 | 2,520 | 22,534 (0%) | 0% | 13.7 | 34,398 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 13.62 per share. | 15 May 2025 | 2,520 | 17,494 (0%) | 0% | 13.6 | 34,317 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 13.76 per share. | 13 May 2025 | 6,300 | 14,974 (0%) | 0% | 13.8 | 86,691 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 13.76 per share. | 13 May 2025 | 2,374 | 8,674 (0%) | 0% | 13.8 | 32,661 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 13.60 per share. | 09 May 2025 | 6,300 | 6,300 (0%) | 0% | 13.6 | 85,691 | Common Stock |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 44.11 per share. | 14 Mar 2025 | 528 | 168,651 (0%) | 0% | 44.1 | 23,291 | Common Stock |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 43.95 per share. | 14 Mar 2025 | 21 | 168,672 (0%) | 0% | 44.0 | 923 | Common Stock |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 43.77 per share. | 10 Mar 2025 | 963 | 168,123 (0%) | 0% | 43.8 | 42,155 | Common Stock |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 42.66 per share. | 10 Mar 2025 | 758 | 166,583 (0%) | 0% | 42.7 | 32,339 | Common Stock |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 43.37 per share. | 10 Mar 2025 | 577 | 167,160 (0%) | 0% | 43.4 | 25,023 | Common Stock |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 43.89 per share. | 06 Mar 2025 | 1,335 | 165,245 (0%) | 0% | 43.9 | 58,597 | Common Stock |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 43.21 per share. | 06 Mar 2025 | 580 | 165,825 (0%) | 0% | 43.2 | 25,064 | Common Stock |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 45.55 per share. | 04 Mar 2025 | 1,279 | 163,587 (0%) | 0% | 45.5 | 58,257 | Common Stock |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 44.55 per share. | 04 Mar 2025 | 267 | 163,910 (0%) | 0% | 44.5 | 11,894 | Common Stock |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 45.96 per share. | 04 Mar 2025 | 56 | 163,643 (0%) | 0% | 46.0 | 2,574 | Common Stock |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 37.40 per share. | 18 Sep 2024 | 115 | 162,308 (0%) | 0% | 37.4 | 4,301 | Common Stock |
| MBX Biosciences Inc. | Patrick J. Heron | Director, Ten Percent Owner | 16 Sep 2024 | 28,297,265 | 0 | - | - | Series B Convertible Preferred Stock | ||
| MBX Biosciences Inc. | Patrick J. Heron | Director, Ten Percent Owner | 16 Sep 2024 | 18,922,852 | 0 | - | - | Series A Convertible Preferred Stock | ||
| MBX Biosciences Inc. | Patrick J. Heron | Director, Ten Percent Owner | 16 Sep 2024 | 3,927,774 | 3,927,774 | - | - | Common Stock | ||
| MBX Biosciences Inc. | Patrick J. Heron | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 16 Sep 2024 | 625,000 | 4,552,774 | - | 16 | 10,000,000 | Common Stock |
| MBX Biosciences Inc. | Patrick J. Heron | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 15,963 | 15,963 | - | - | Stock Option (Right to Buy) | |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 41.58 per share. | 06 Sep 2024 | 230 | 162,193 (0%) | 0% | 41.6 | 9,563 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick J. Heron | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 27,052 | 27,052 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick J. Heron | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 10,139 | 18,826 (0%) | 0% | 0 | Common Stock | |
| HilleVax Inc | Patrick J. Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 22,500 | 22,500 | - | - | Stock Option | |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 8,779 | 8,779 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 5,703 | 5,703 | - | - | Restricted Stock Units | |
| Arcutis Biotherapeutics Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 9.50 per share. | 04 Mar 2024 | 21,052 | 8,785,284 (23%) | 0% | 9.5 | 199,994 | Common Stock |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 28.30 per share. | 09 Nov 2023 | 2,910 | 161,963 (0%) | 0% | 28.3 | 82,353 | Common Stock |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 31.02 per share. | 13 Sep 2023 | 2,625 | 159,053 (0%) | 0% | 31.0 | 81,425 | Common Stock |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 30.30 per share. | 11 Sep 2023 | 4,687 | 152,678 (0%) | 0% | 30.3 | 142,027 | Common Stock |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 30.60 per share. | 11 Sep 2023 | 3,750 | 156,428 (0%) | 0% | 30.6 | 114,764 | Common Stock |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 26.25 per share. | 31 Aug 2023 | 147,991 | 147,991 (0%) | 0% | 26.3 | 3,884,764 | Common Stock |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 17,000 | 17,000 | - | - | Stock Option (right to buy) | |
| HilleVax Inc | Patrick J. Heron | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 22,500 | 22,500 | - | - | Stock Option | |
| Arcutis Biotherapeutics Inc | Patrick J. Heron | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 12,220 | 12,220 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick J. Heron | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 4,375 | 8,687 (0%) | 0% | 0 | Common Stock | |
| HilleVax Inc | Patrick J. Heron | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2022 | 25,000 | 25,000 | - | - | Stock Option | |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 17,000 | 17,000 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick J. Heron | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 11,796 | 11,796 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Patrick J. Heron | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 4,312 | 4,312 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick J. Heron | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 13,391 | 13,391 | - | - | Stock Option (Right to Buy) | |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 17,000 | 17,000 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Patrick J. Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Iterum Therapeutics Plc | Patrick J. Heron | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 2,852 | 0 | - | - | Restricted Stock Units | |
| Iterum Therapeutics Plc | Patrick J. Heron | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2020 | 2,852 | 9,006 (0%) | 0% | - | Ordinary Shares | |
| Vaxcyte Inc | Patrick J. Heron | Director | 16 Jun 2020 | 1,692,494 | 1,692,494 | - | - | Common Stock | ||
| Vaxcyte Inc | Patrick J. Heron | Director | 16 Jun 2020 | 1,692,494 | 0 | - | - | Series B Preferred Stock | ||
| Vaxcyte Inc | Patrick J. Heron | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 16 Jun 2020 | 250,000 | 2,309,554 | - | 16 | 4,000,000 | Common Stock |
| Vaxcyte Inc | Patrick J. Heron | Director | 16 Jun 2020 | 226,236 | 1,918,730 | - | - | Common Stock | ||
| Vaxcyte Inc | Patrick J. Heron | Director | 16 Jun 2020 | 226,236 | 0 | - | - | Series C Preferred Stock | ||
| Vaxcyte Inc | Patrick J. Heron | Director | 16 Jun 2020 | 140,824 | 2,059,554 | - | - | Common Stock | ||
| Vaxcyte Inc | Patrick J. Heron | Director | 16 Jun 2020 | 140,824 | 0 | - | - | Series D Preferred Stock | ||
| Vaxcyte Inc | Patrick J. Heron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Patrick J. Heron | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 17,000 | 17,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges